Disc Medicine, Inc. — Director's Dealing 2021

Oct 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-10-18

Reporting Person: Piekos Brian (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-18	Restricted Stock Units	$	A	90720	Acquired		Common Stock (90720)	Direct

Footnotes

F1: Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.

F2: Thirty-three percent (33%) of the Restricted Stock Units shall vest upon the achievement of a clinical milestone, and the remaining sixty-seven percent (67%) of the Restricted Stock Units shall vest on the one (1)-year anniversary of the achievement of this clinical milestone.